Skip to main content
. 2019 Jul 10;10(8):1725–1735. doi: 10.1111/1759-7714.13144

Table 1.

Characteristics of patients in the entire cohort

Clinicopathological characteristics Stratified by Site Lower Upper P
Number of patients 5803 375
Nodal status (%) Regional node metastasis 4723 (81.4) 323 (86.1) 0.067
Supraclavicular node (station 1) metastasis 492 (8.5) 25 (6.7)
Celiac node (station 20) metastasis 588 (10.1) 27 (7.2)
Age at diagnosis (mean [SD]) 64.83 (11.10) 65.35 (10.73) 0.377
Sex (%) Female 816 (14.1) 119 (31.7) <0.001
Male 4987 (85.9) 256 (68.3)
CHSDA region (%) East 2224 (38.3) 163 (43.5) 0.167
NP 743 (12.8) 39 (10.4)
PC 2594 (44.7) 161 (42.9)
SW 242 (4.2) 12 (3.2)
Marital status (%) Married (including common law) 3850 (66.3) 183 (48.8) <0.001
Separated/widowed/divorced 1159 (20.0) 117 (31.2)
Single (never married) 794 (13.7) 75 (20.0)
Histology type (%) Adenocarcinoma 4372 (75.3) 32 (8.5) <0.001
Squamous cell carcinoma 816 (14.1) 328 (87.5)
Others 615 (10.6) 15 (4.0)
T stage (%) T1 819 (14.1) 58 (15.5) <0.001
T2 805 (13.9) 50 (13.3)
T3 3544 (61.1) 169 (45.1)
T4 635 (10.9) 98 (26.1)
N stage (%) N0 2263 (39.0) 116 (30.9) 0.002
N1 3540 (61.0) 259 (69.1)
Tumor size (%) ≤5 cm 2562 (44.1) 169 (45.1) 0.809
>5 cm 1603 (27.6) 106 (28.3)
Unknown 1638 (28.2) 100 (26.7)
Surgery (%) No 2949 (50.8) 325 (86.7) <0.001
Yes 2854 (49.2) 50 (13.3)
Surgery type (%) Esophagectomy 2827 (48.7) 44 (11.7) <0.001
Endoscopic treatment 27 (0.5) 6 (1.6)
Radiotherapy (%) No 1311 (22.6) 69 (18.4) 0.068
Yes 4492 (77.4) 306 (81.6)
Chemotherapy (%) No/unknown 944 (16.3) 75 (20.0) 0.069
Yes 4859 (83.7) 300 (80.0)
Race (%) White 5293 (91.2) 257 (68.5) <0.001
Black 277 (4.8) 72 (19.2)
Others 233 (4.0) 46 (12.3)
Grade (%) G1 240 (4.1) 22 (5.9) 0.002
G2 2230 (38.4) 175 (46.7)
G3 3227 (55.6) 173 (46.1)
G4 106 (1.8) 5 (1.3)
Diagnosed year (%) 2004–2009 2446 (42.2) 133 (35.5) 0.013
2010–2015 3357 (57.8) 242 (64.5)

CHSDA, Contract Health Service Delivery Areas; NP, Northern Plains; PC, Pacific Coast; SW, South West; SD, standard deviation.